"1-Naphthylamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A suspected industrial carcinogen (and listed as such by OSHA). Its N-hydroxy metabolite is strongly carcinogenic and mutagenic.
| Descriptor ID |
D015057
|
| MeSH Number(s) |
D02.092.705 D02.455.426.559.847.638.845 D04.615.638.845
|
| Concept/Terms |
1-Naphthylamine- 1-Naphthylamine
- 1 Naphthylamine
- 1-Aminonaphthalene
- 1 Aminonaphthalene
- 8-Aminonaphthalene
- 8 Aminonaphthalene
- alpha-Naphthylamine
- alpha Naphthylamine
- Naphthalidine
|
Below are MeSH descriptors whose meaning is more general than "1-Naphthylamine".
Below are MeSH descriptors whose meaning is more specific than "1-Naphthylamine".
This graph shows the total number of publications written about "1-Naphthylamine" by people in this website by year, and whether "1-Naphthylamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "1-Naphthylamine" by people in Profiles.
-
Role of small-conductance calcium-activated potassium channels in atrial electrophysiology and fibrillation in the dog. Circulation. 2014 Jan 28; 129(4):430-40.
-
Challenges in obesity management. South Med J. 1998 Aug; 91(8):710-20.
-
Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder. Am J Psychiatry. 1997 Sep; 154(9):1293-5.
-
High doses of sertraline for treatment-resistant obsessive-compulsive disorder. Am J Psychiatry. 1996 Sep; 153(9):1232-3.
-
"Impending death" and sertraline. J Emerg Med. 1995 Mar-Apr; 13(2):246.
-
The pharmacotherapy of obsessive-compulsive disorder. Pharmacopsychiatry. 1993 May; 26 Suppl 1:24-9.
-
Pharmacotherapy of obsessive compulsive disorder. J Clin Psychiatry. 1992 Apr; 53 Suppl:29-37.
-
Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacol Bull. 1990; 26(3):279-84.